Press "Enter" to skip to content

Sanofi ends research in diabetes, narrows units to spur profit

Sanofi SA said on Monday it would end its research efforts in diabetes and cardiovascular diseases as part of a revamp that will narrow the number of its business units in the hope of bolstering growth and profit.

Original source:

Also Read:   Leaving the hospital early can double the odds of going back